GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » Days Sales Outstanding

Genetron Holdings (Genetron Holdings) Days Sales Outstanding : 200.74 (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings Days Sales Outstanding?

Genetron Holdings's average Accounts Receivable for the three months ended in Jun. 2022 was $45.26 Mil. Genetron Holdings's Revenue for the three months ended in Jun. 2022 was $20.57 Mil. Hence, Genetron Holdings's Days Sales Outstanding for the three months ended in Jun. 2022 was 200.74.

The historical rank and industry rank for Genetron Holdings's Days Sales Outstanding or its related term are showing as below:

GTH's Days Sales Outstanding is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 69.88
* Ranked among companies with meaningful Days Sales Outstanding only.

Genetron Holdings's Days Sales Outstanding increased from Jun. 2021 (128.46) to Jun. 2022 (200.74).


Genetron Holdings Days Sales Outstanding Historical Data

The historical data trend for Genetron Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings Days Sales Outstanding Chart

Genetron Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Days Sales Outstanding
Get a 7-Day Free Trial 40.72 69.26 104.34 151.79 154.80

Genetron Holdings Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 147.35 173.37 232.61 200.74 -

Competitive Comparison of Genetron Holdings's Days Sales Outstanding

For the Diagnostics & Research subindustry, Genetron Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetron Holdings's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetron Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Genetron Holdings's Days Sales Outstanding falls into.



Genetron Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Genetron Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

Days Sales Outstanding (A: Dec. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2021 ) + Accounts Receivable (A: Dec. 2022 )) / count ) / Revenue (A: Dec. 2022 )*Days in Period
=( (44.293 + 34.873) / 2 ) / 93.335*365
=39.583 / 93.335*365
=154.80

Genetron Holdings's Days Sales Outstanding for the quarter that ended in Jun. 2022 is calculated as:

Days Sales Outstanding (Q: Jun. 2022 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Jun. 2022 )) / count ) / Revenue (A: Jun. 2022 )*Days in Period
=( (44.358 + 46.161) / 2 ) / 20.574*365 / 4
=45.2595 / 20.574*365 / 4
=200.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetron Holdings  (NAS:GTH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Genetron Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetron Holdings (Genetron Holdings) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.